Kay Stubenrauch

2.5k total citations
33 papers, 1.4k citations indexed

About

Kay Stubenrauch is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Kay Stubenrauch has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Radiology, Nuclear Medicine and Imaging, 19 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Kay Stubenrauch's work include Monoclonal and Polyclonal Antibodies Research (23 papers), Biosimilars and Bioanalytical Methods (15 papers) and Protein purification and stability (9 papers). Kay Stubenrauch is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (23 papers), Biosimilars and Bioanalytical Methods (15 papers) and Protein purification and stability (9 papers). Kay Stubenrauch collaborates with scholars based in Germany, Switzerland and United States. Kay Stubenrauch's co-authors include Jörg T. Regula, Uwe Wessels, Christian Klein, Hubert Kettenberger, Julia Schleypen, Claudio Sustmann, Wolfgang Schaefer, Rebecca Croasdale, Markus Thomas and Jürgen Schanzer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

Kay Stubenrauch

32 papers receiving 1.3k citations

Peers

Kay Stubenrauch
Nadine Tuaillon United States
Randy Robinson United States
Huaizu Guo China
Namir J. Hassan United Kingdom
S T Ju United States
Shigeto Kawai Japan
M. Carrie Miceli United States
Julie Stewart United States
Tong‐Yuan Yang United States
Sašo Čemerski United States
Nadine Tuaillon United States
Kay Stubenrauch
Citations per year, relative to Kay Stubenrauch Kay Stubenrauch (= 1×) peers Nadine Tuaillon

Countries citing papers authored by Kay Stubenrauch

Since Specialization
Citations

This map shows the geographic impact of Kay Stubenrauch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Stubenrauch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Stubenrauch more than expected).

Fields of papers citing papers by Kay Stubenrauch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Stubenrauch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Stubenrauch. The network helps show where Kay Stubenrauch may publish in the future.

Co-authorship network of co-authors of Kay Stubenrauch

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Stubenrauch. A scholar is included among the top collaborators of Kay Stubenrauch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Stubenrauch. Kay Stubenrauch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lechmann, Martin, Katharine Bray‐French, Anneliese Schneider, et al.. (2025). Comparable immunogenicity of new modality biotherapeutics delivered subcutaneously or intravenously in non-human primates. Journal of Immunotoxicology. 22(1). 2537408–2537408.
2.
3.
Engel, Alfred M., et al.. (2021). Assay Concept for Detecting Anti-Drug IgM in Human Serum Samples by using a Novel Recombinant Human IgM Positive Control. Bioanalysis. 13(4). 253–263. 4 indexed citations
4.
Regula, Jörg T., Peter Lundh von Leithner, Richard M. FOXTON, et al.. (2017). Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases. EMBO Molecular Medicine. 9(7). 985–985. 7 indexed citations
5.
Burmester, Gerd R, Ernest Choy, Alan Kivitz, et al.. (2016). Low immunogenicity of tocilizumab in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 76(6). 1078–1085. 82 indexed citations
6.
Regula, Jörg T., Peter Lundh von Leithner, Richard Foxton, et al.. (2016). Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases. EMBO Molecular Medicine. 8(11). 1265–1288. 241 indexed citations
7.
Stubenrauch, Kay, et al.. (2015). Epitope characterization of the ADA response directed against a targeted immunocytokine. Journal of Pharmaceutical and Biomedical Analysis. 114. 296–304. 14 indexed citations
8.
Stubenrauch, Kay, et al.. (2014). An immunodepletion procedure advances free angiopoietin-2 determination in human plasma samples during anti-cancer therapy with bispecific anti-Ang2/VEGF CrossMab. Journal of Pharmaceutical and Biomedical Analysis. 102. 459–467. 5 indexed citations
9.
Hoffmann, Eike, Anish Konkar, Sebastian Dziadek, et al.. (2013). PK modulation of haptenylated peptides via non-covalent antibody complexation. Journal of Controlled Release. 171(1). 48–56. 8 indexed citations
10.
11.
Klein, Christian, Claudio Sustmann, Markus Thomas, et al.. (2012). Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies. mAbs. 4(6). 653–663. 157 indexed citations
12.
Stubenrauch, Kay, et al.. (2012). Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodies. Analytical Biochemistry. 430(2). 193–199. 15 indexed citations
13.
Schaefer, Wolfgang, Jörg T. Regula, Monika Bähner, et al.. (2011). Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies. Proceedings of the National Academy of Sciences. 108(27). 11187–11192. 334 indexed citations
14.
Stubenrauch, Kay, et al.. (2010). Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies. Journal of Pharmaceutical and Biomedical Analysis. 52(2). 249–254. 38 indexed citations
15.
Stubenrauch, Kay, Uwe Wessels, & Helmut Lenz. (2009). Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates. Journal of Pharmaceutical and Biomedical Analysis. 49(4). 1003–1008. 34 indexed citations
16.
Stubenrauch, Kay, Uwe Wessels, Jörg T. Regula, et al.. (2009). Impact of Molecular Processing in the Hinge Region of Therapeutic IgG4 Antibodies on Disposition Profiles in Cynomolgus Monkeys. Drug Metabolism and Disposition. 38(1). 84–91. 37 indexed citations
17.
Röcken, Christoph, Barbara Stix, Kay Stubenrauch, et al.. (2003). Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis. American Journal Of Pathology. 162(4). 1213–1220. 38 indexed citations
18.
Stubenrauch, Kay, Stefan Gleiter, Ulrich Brinkmann, Rainer Rudolph, & Hauke Lilie. (2001). Conjugation of an antibody Fv fragment to a virus coat protein: cell-specific targeting of recombinant polyoma-virus-like particles. Biochemical Journal. 356(3). 867–867. 33 indexed citations
19.
Stubenrauch, Kay, Anthony W. Bachmann, Rainer Rudolph, & Hauke Lilie. (2000). Purification of a viral coat protein by an engineered polyionic sequence. Journal of Chromatography B Biomedical Sciences and Applications. 737(1-2). 77–84. 26 indexed citations
20.
Gleiter, Stefan, Kay Stubenrauch, & Hauke Lilie. (1999). Changing the surface of a virus shell fusion of an enzyme to polyoma VP1. Protein Science. 8(12). 2562–2569. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadine Tuaillon Breakdown of academic impact, for papers by Randy Robinson Breakdown of academic impact, for papers by Huaizu Guo Breakdown of academic impact, for papers by Namir J. Hassan Breakdown of academic impact, for papers by S T Ju Breakdown of academic impact, for papers by Shigeto Kawai Breakdown of academic impact, for papers by M. Carrie Miceli Breakdown of academic impact, for papers by Julie Stewart Breakdown of academic impact, for papers by Tong‐Yuan Yang Breakdown of academic impact, for papers by Sašo Čemerski
Rankless by CCL
2026